(R)-NX-2127

CAT:
804-HY-153220A-03
Size:
25 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(R)-NX-2127 - image 1

(R)-NX-2127

  • CAS Number: 3024312-52-2
  • UNSPSC Description: (R)-NX-2127 ((R)-compound 28) is an isomer of the BTK PROTAC degrader NX-2127 (HY-153220)[1]. (R)-NX-2127 is composed of PROTAC target protein ligand (red part) BTK ligand 10 (HY-168302), E3 ligase ligand (blue part) Thalidomide 5-fluoride (HY-W087383) and PROTAC Linker (black part) Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 (HY-168304).
  • Target Antigen: Btk; PROTACs
  • Type: Reference compound
  • Related Pathways: PROTAC;Protein Tyrosine Kinase/RTK
  • Applications: COVID-19-immunoregulation
  • Field of Research: Cancer; Inflammation/Immunology
  • Assay Protocol: https://www.medchemexpress.com/r-nx-2127.html
  • Solubility: 10 mM in DMSO
  • Smiles: O=C1C2=CC(N3C[C@@H](CN4CCC(C5=CC=C(C=C5)NC6=C(N=CC(N7CCCCC7)=N6)C(N)=O)CC4)CC3)=CC=C2C(N1C8C(NC(CC8)=O)=O)=O
  • Molecular Weight: 719.83
  • References & Citations: [1]Robbins DW, et al. Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies. J Med Chem. 2024 Feb 22;67(4):2321-2336.
  • Shipping Conditions: Room temperature
  • Clinical Information: No Development Reported